Atlas Private Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,329
Closed -$208K 166
2023
Q4
$208K Sell
2,329
-742
-24% -$55.1K 0.04% 153
2023
Q3
$224K Sell
3,071
-350
-10% -$28K 0.04% 166
2023
Q2
$285K Buy
+3,421
New +$286K 0.06% 153
2022
Q2
Sell
-3,137
Closed -$282K 147
2022
Q1
$282K Sell
3,137
-51
-2% -$4.71K 0.13% 113
2021
Q4
$357K Hold
3,188
0.17% 105
2021
Q3
$401K Hold
3,188
0.21% 96
2021
Q2
$432K Sell
3,188
-158
-5% -$20.8K 0.23% 82
2021
Q1
$454K Buy
3,346
+163
+5% +$24.4K 0.25% 79
2020
Q4
$448K Buy
3,183
+179
+6% +$22.9K 0.3% 73
2020
Q3
$335K Buy
3,004
+40
+1% +$4.48K 0.28% 75
2020
Q2
$332K Buy
+2,964
New +$292K 0.3% 76

Other funds holding XBI